CONMED CORP (CNMD) — insider trading
Health Care · NYSE
CONMED CORP (CNMD) has 18 reported SEC Form 4 insider transactions in our data (latest 2026-07-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | Mirviss Jeffrey B. | Director | Grant / award / vesting (derivative) | 5,603 | $0.00 | $0 | Form 4 |
| 2026-07-01 | Martin Celine Christine | Director | Grant / award / vesting (derivative) | 5,603 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Schwarzentraub Barbara J | Director | Option exercise / conversion (derivative) | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Schwarzentraub Barbara J | Director | Option exercise / conversion | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Kaye Mark | Director | Option exercise / conversion (derivative) | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Kaye Mark | Director | Option exercise / conversion | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Farkas Charles | Director | Option exercise / conversion (derivative) | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Farkas Charles | Director | Option exercise / conversion | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Council LaVerne H | Director | Option exercise / conversion (derivative) | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Council LaVerne H | Director | Option exercise / conversion | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Bronson David M. | Director | Option exercise / conversion (derivative) | 668 | $0.00 | $0 | Form 4 |
| 2026-06-02 | Bronson David M. | Director | Option exercise / conversion | 668 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Schwarzentraub Barbara J | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Kaye Mark | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Farkas Charles | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Kelderman Kim | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Council LaVerne H | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
| 2026-06-01 | Bronson David M. | Director | Grant / award / vesting (derivative) | 5,772 | $0.00 | $0 | Form 4 |
Ask the chat about CNMD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CONMED CORP (CNMD).
Last updated 2026-07-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.